Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Rheumatology | Family Medicine

Psoriasis and Psoriatic Disorders Clinical Trials

A listing of Psoriasis and Psoriatic Disorders medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Arizona

Arizona Research Center
Phoenix Arizona 85023

A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214(Study Medication) Versus Enbrel in Subjects With Chronic Plaque Psoriasis.

California

University of California, Irvine Dermatology Clinical Research Center
Irvine California

A Multi-Center, Open Label, Phase 1 Study to Evaluate the Safety of Both A Prospective, Observational Study to Estimate the Proportion of Subjects with Plaque Psoriasis who Achieve Complete Clearance on Biologics

University of California, Irvine Dermatology Clinical Research Center
Irvine California 92697

Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects with Moderate to Severe Plaque Psoriasis Who Have Lost a Satisfactory Response to Adalimumab

Dermatology Specialists, Inc.
Oceanside California 92056

A national, multi-center, randomized, double-blind, 4 arm, 8 week study in subjects with psoriasis vulgaris on the non-scalp regions of the body (trunk and/or limbs)

Dermatology Specialists, Inc.
Oceanside California 92056

A Phase 3, Multi-site, randomized, mixed-blind, parallel-group treatment withdrawl and re-treatment study of the efficacy and safety of 2 oral doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis

Dermatology Specialists, Inc.
Oceanside California 92056

You may be interested in learning about a clinical research study of an investigational study medication for symptoms associated with plaque psoriasis

Florida

Massachusetts

New Jersey

New York

Sadick Research Group
New York New York 10075

A 12-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients with Moderate to Severe Plaque Psoriasis with a Long-Term Extension Period

The Rockefeller University Hospital
New York New York 10065

Comparative analysis of small and large plaque psoriasis

Rockefeller University
New York New York 10065

Efficacy of Ustekinumab (Anti-IL-12/23) followed by Abatacept (CTLA4-Ig)for the Treatment of Psoriasis Vulgaris (PAUSE)

North Carolina

PMG Research of Cary
Cary North Carolina 27518

Plaque Psoriasis – Diagnosed for at least 6 months

PMG Research of Cary
Cary North Carolina 27518

Plaque Psoriasis – Moderate to Severe

PMG Research of Cary
Cary North Carolina 27518

Psoriasis can be itchy and painful.

PMG Research of Charlotte
Charlotte North Carolina 28209

Psoriasis - Moderate to Severe Plaque Psoriasis

PMG Research of Charlotte
Charlotte North Carolina 28209

Psoriasis is a common skin condition that causes skin redness and irritation.

PMG Research of Wilmington
Wilmington North Carolina 28401

Plaque Psoriasis – Diagnosed for at least 6 months

Rhode Island

Clinical Partners, LLC
Johnston Rhode Island 02919

Opportunity to participate: New Psoriasis Study Being Conducted

South Carolina

Tennessee

PMG Research of Bristol
Bristol Tennessee 37620

Pediatric Psoriasis Research Study

PMG Research of Bristol
Bristol Tennessee 37620

Plaque Psoriasis – Diagnosed for at least 6 months

PMG Research of Bristol
Bristol Tennessee 37620

Plaque Psoriasis – Not adequately controlled with other common psoriasis treatments

PMG Research of Bristol
Bristol Tennessee 37620

Psoriasis - Moderate to Severe Plaque Psoriasis

Texas

Research Across America, Plano
Plano Texas

Plaque Psoriasis Research Study

Dermatology Clinical Research Center of San Antonio
San Antonio Texas 78229

A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects with Moderate-to-Severe Chronic Plaque-Type Psoriasis

Dermatology Clinical Research Center of San Antonio
San Antonio Texas 78229

A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of Betamethasone Dipropionate Spray 0.05% in the Treatment of Moderate Plaque Psoriasis

Dermatology Clinical Research Center of San Antonio
San Antonio Texas 78229

A Randomized, Vehicle-Controlled, Double-Blind, Parallel Group, Multi-Center Phase III Study to Evaluate the Safety and Efficacy of M518101 in Subjects with Plaque Psoriasis

Utah

The University of Utah
Salt Lake City Utah 84132

Efficacy of Ustekinumab (Anti-IL-12/23) followed by Abatacept (CTLA4-Ig)for the Treatment of Psoriasis Vulgaris (PAUSE)

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.